
Brain magnetic resonance imaging findings and radiologic review of maple syrup urine disease: Report of three cases
Author(s) -
Li Yang,
Xia Liu,
Chongfeng Duan,
Xingxing Song,
Xun-hui Zhuang
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i8.1844
Subject(s) - medicine , maple syrup urine disease , magnetic resonance imaging , radiology , nuclear medicine , biochemistry , chemistry , leucine , amino acid
Maple syrup urine disease (MSUD) is a rare autosomal-recessive disorder that affects branched-chain amino acid (BCAA) metabolism and is named after the distinctive sweet odor of affected infants' urine. This disease is characterized by the accumulation of BCAAs and corresponding branched-chain ketoacids of leucine, isoleucine, and valine in the plasma, urine, and cerebrospinal fluid. However, the mechanisms of MSUD-induced brain damage remain poorly defined. The accumulation of BCAAs in the brain inhibits the activity of pyruvate dehydrogenase and α-ketoglutarate, disrupting the citric acid cycle and consequently impacting the synthesis of amino acids, causing cerebral edema and abnormal myelination.